{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Zentek Ltd."},"Symbol":{"label":"Symbol","value":"ZTEK"},"Address":{"label":"Address","value":"24 CORPORATE CT,SUITE 210, GUELPH, Ontario, N1G 5G5, Canada"},"Phone":{"label":"Phone","value":"+1 844 730-9822"},"Industry":{"label":"Industry","value":"Major Chemicals"},"Sector":{"label":"Sector","value":"Industrials"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection and treatment.?It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19,?and the potential to use?similar?compounds?as pharmaceutical products?against infectious diseases. The company also has an exclusive agreement to be the global commercializing partner for a newly developed, highly scalable, aptamer-based rapid pathogen detection technology."},"CompanyUrl":{"label":"Company Url","value":"https://www.zentek.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Adam MacIntosh","title":"Director-Research & Development"},{"name":"Colin van der Kuur","title":"Chief Scientific Officer"},{"name":"Gregory Fenton","title":"Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}